Related Articles
Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma
RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cells
Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer
Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma